Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
An Alzheimer’s blood biomarker test can’t actually determine whether or not a person has Alzheimer’s disease — but it can help signal to doctors…
Alzheimer’s blood tests: a new frontier in neurodegenerative diagnostics, getting the world a big step closer to earlier, more accessible Alzheimer’s diagnosis. But it’s…
This month is Black History Month. Let’s talk about the impacts that history has on public health in the present: Alzheimer’s doesn’t discriminate, but…
The U.S. is in the midst of a racial reckoning. The COVID-19 pandemic, which took a particularly heavy toll on Black communities, turned a…
What causes Alzheimer’s disease and related forms of progressive dementia? Scientists still don’t know. One leading theory points to beta-amyloid protein — a biomarker…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Caribbean neuroscientist Indira Turney’s research is centered…
Experts estimate that, by 2023, nearly 40 percent of the more than eight million Americans living with Alzheimer’s and related dementias will be Latino…
By 2030, experts estimate that more than 8 million Americans will be living with Alzheimer’s or other forms of dementia. Black Americans will make…
Biogen renounced ownership of their controversial anti-Alzheimer’s drug Aduhelm after years of dismal sales. The company is also halting an ongoing clinical trial set…
About 14 of every 100 of Black Americans older than 65 have Alzheimer’s disease, compared 10 in 100 white Americans of the same age…
Blacks are at higher risk for several health conditions in the U.S. This is true for heart disease, hypertension, type 2 diabetes and stroke,…
As Alzheimer’s and other forms of dementia progress, brain cells and their connections degenerate and die, including those crucial for recalling old memories. That…
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data…
As we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurological disorders, increases significantly. However, while we all…